on Monday said its board will meet on September 11 to consider a proposal for buyback of equity shares. In 2022, the company had bought back shares worth ₹9,300 crore via an open market transaction.
informed the exchanges that it has stopped manufacturing Vecuronium Bromide Injection 20 MG, a neuromuscular blocking agent used in general anaesthesia. The US FDA has officially acknowledged this discontinuation. This decision may impact healthcare providers who regularly use this medication, potentially requiring them to seek alternative suppliers or consider other neuromuscular blocking agents. Sun Pharma has not provided specific reasons for the discontinuation or announced any plans to replace the product.
informed the exchanges that its Singapore-based subsidiary has entered into a strategic product development partnership with Kenox Pharmaceuticals Inc, which will strengthen the pipeline of nasal spray products across diverse therapeutic areas. Strides Pharma Global Pte, Singapore will collaborate with Kenox on the development and filing of multiple nasal spray products for the US market across diverse therapeutic indications, a joint statement said.
has won multiple orders totalling approximately ₹456 crore from the Bihar Education Project Council. The projects include setting up smart classrooms for middle, secondary, and senior secondary schools, ICT labs, teaching learning material, and ISM lab set-up. Most projects have a completion deadline of March 31, 2026, with the ISM lab project due by December 31, 2025. These domestic orders signify Railtel’s growing presence in the education technology sector and are expected to positively impact the company’s financial performance.
has spent more than ₹12,500 crore to boost metal manufacturing for the growing needs of the nation’s electric vehicle sector. The company produces a wide range of products, including aluminium, zinc, value-added alloys, copper, steel, nickel and ferrochrome. “To boost production of these critical enablers for the EV industry, Vedanta has spent more than ₹12,500 crore. The investments include capacity expansion across aluminium smelter, boosting aluminium value-added products, setting up a zinc alloy plant, roaster set-up for zinc production and ferrochrome capacity augmentation,” the company said in a statement.
has entered into a new strategic collaboration with Cisco in the area of eSIM and IoT (Internet of Things) connectivity. The collaboration will embed Tata Communications MOVE, an intelligent, multi-generational, global eSIM orchestration solution, delivering 350-plus million eSIM Operating Systems (OS) and managed SIM lifecycle, into Cisco’s IoT Control Center, a device management platform cloud offering that is used by over 32,000 enterprises and supporting more than 270 million SIM IoT devices (including 100 million connected cars), according to a release.
(SFB) aims to raise ₹2,000 crore in core capital in up to two years to fund growth plans, a top official said on Monday. The microlender-turned-SFB has also announced a slew of business plans, including expansion of branch network to 1,150 from the present 752, and a nearly three-times growth in loanbook over the next five years. “We will be raising ₹2,000 crore capital in 18-24 months through the qualified institutional placement (QIP) route,” its Managing Director and Chief Executive Sanjeev Nautiyal told reporters here.
on Monday said its toll revenue rose by 12 per cent to ₹563 crore in August 2025, compared to the year-ago month. Toll collection revenues stood at ₹503 crore in the same month last year, IRB said in an exchange filing. Of its 17 tolls, IRB MP Expressway in Maharashtra contributed ₹147.7 crore to the total revenue collection in August, up from ₹142.1 crore in August 2024.